These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 13783846)

  • 1. Changes in the concentration and intracellular distribution of brain catecholamines: the effects of reserpine. beta-phenyliso-propylhydrazine, pyrogallol and 3,4-dihydroxyphenyl alanine, alone and in combination.
    WEIL-MALHERBE H; POSNER HS; BOWLES GR
    J Pharmacol Exp Ther; 1961 Jun; 132():278-86. PubMed ID: 13783846
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of the reserpine-induced depletion of brain serotonin by a monoamine oxidase inhibitor.
    CANAL N; MAFFEI-FACCIOLI A
    J Neurochem; 1959 Dec; 5():99-100. PubMed ID: 13807360
    [No Abstract]   [Full Text] [Related]  

  • 3. An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
    Przegaliński E; Kleinrok Z
    Psychopharmacologia; 1972; 23(3):279-88. PubMed ID: 4260342
    [No Abstract]   [Full Text] [Related]  

  • 4. Intracellular distribution of norepinephrine in rat brain. I. Effect of reserpine and the monoamine oxidase inhibitors, trans-2-phenylcyclopropylamine and 1-isonicotinyl-2-isopropyl hydrazine.
    GREEN H; SAWYER JL
    J Pharmacol Exp Ther; 1960 Jul; 129():243-9. PubMed ID: 13851489
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenergic mechanism of the drugs. Systemic arterial pressure changes caused by intravenous injection of reserpine following the administration of pheniprazine and pyrogallol in anesthetized dogs.
    Takasak K
    Kurume Med J; 1966; 13(3):99-111. PubMed ID: 4381259
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of L-DOPA on brain catecholamines and motility in rats.
    Maj J; Grabowska M; Mogilnicka E
    Psychopharmacologia; 1971; 22(2):162-71. PubMed ID: 5124189
    [No Abstract]   [Full Text] [Related]  

  • 7. The action of nialamide on the concentration of catechol amines in heart and brain stem.
    MUSCHOLL E
    Med Esp; 1959; 1():363-7. PubMed ID: 14425478
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-induced changes in monoamine levels in the sympathetic adrenergic ganglion cells and terminals. A histochemical study.
    Norberg KA
    Acta Physiol Scand; 1965 Nov; 65(3):221-34. PubMed ID: 4379526
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
    Bartholini G; Blum JE; Pletscher A
    J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective reserpine-resistant accumulation of catecholamines in central dopamine neurones after DOPA administration.
    Lidbrink P; Jonsson G; Fuxe K
    Brain Res; 1974 Mar; 67(3):439-56. PubMed ID: 4470434
    [No Abstract]   [Full Text] [Related]  

  • 11. FUNCTION AND METABOLISM OF CATECHOLAMINES IN THE BRAIN.
    MATSUOKA M
    Jpn J Pharmacol; 1964 Jun; 14():181-93. PubMed ID: 14215546
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanism of contraction caused by nicotine on the isolated rabbit aorta, with reference to catecholamine release].
    Funasaka T
    Nihon Yakurigaku Zasshi; 1967 Jul; 63(4):261-72. PubMed ID: 4383572
    [No Abstract]   [Full Text] [Related]  

  • 13. CORRELATION BETWEEN BRAIN CATECHOLAMINE AND SEDATIVE ACTION OF RESERPINE.
    MATSUOKA M; YOSHIDA H; IMAIZUMI R
    Nature; 1964 Apr; 202():198. PubMed ID: 14159603
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine.
    Benkert O; Gluba H; Matussek N
    Neuropharmacology; 1973 Mar; 12(3):177-86. PubMed ID: 4735415
    [No Abstract]   [Full Text] [Related]  

  • 15. The action L-dopa on sexual behaviour of male rats.
    Da Prada M; Carruba M; Saner A; O'Brien A; Pletscher A
    Brain Res; 1973 Jun; 55(2):383-9. PubMed ID: 4541349
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional aspects of 5-hydroxytryptamine turnover in the central nervous system.
    Modigh K
    Acta Physiol Scand Suppl; 1974; 403():1-56. PubMed ID: 4275711
    [No Abstract]   [Full Text] [Related]  

  • 17. The inhibitory action of the sympathetic nerves on the smooth muscle of the rabbit gut, its reversal by reserpine and restoration by catechol amines and by DOPA.
    GILLESPIE JS; MACKENNA BR
    J Physiol; 1961 Apr; 156(1):17-34. PubMed ID: 13705341
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of l-dopa on the development of reserpine parkinsonism and the metabolism of catecholamines in rats].
    Samoĭlova ZT; Tret'iakova KA; Khaliutina LV
    Farmakol Toksikol; 1973; 36(5):684-7. PubMed ID: 4802196
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversal of the reserpine-induced suppression of the conditioned avoidance response by L-dopa: correlation of behavioral and biochemical differences in two strains of mice.
    Seiden LS; Peterson DD
    J Pharmacol Exp Ther; 1968 Feb; 159(2):422-8. PubMed ID: 5638661
    [No Abstract]   [Full Text] [Related]  

  • 20. [Research on the benzodioxan series. XIX. Hydrazine derivatives of 1, 4-benzodioxan. Synthesis and pharmacological properties].
    MARINI-BETTOLO GB; LANDI VITTORY R; JORIO MA; BOVET-NITTI F; ORSINGHER O
    Rend Ist Sup Sanit; 1960; 23():1110-27. PubMed ID: 13766823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.